Science
Rigel Pharmaceuticals (NASDAQ: RIGL) Has Succeeded In Generating Interest In 2025, The Stock Is Up 20.10% Year-To-Date
Rigel Pharmaceuticals (NASDAQ:RIGL)’s traded shares stood at 0.67 million during the last session, with the company’s beta value hitting 1.27. At the close of trading,
